Connection

OLGA GORLOVA to Humans

This is a "connection" page, showing publications OLGA GORLOVA has written about Humans.
Connection Strength

0.328
  1. Identification of lung cancer drivers by comparison of the observed and the expected numbers of missense and nonsense mutations in individual human genes. Oncotarget. 2022; 13:756-767.
    View in: PubMed
    Score: 0.016
  2. SNP characteristics and validation success in genome wide association studies. Hum Genet. 2022 Feb; 141(2):229-238.
    View in: PubMed
    Score: 0.016
  3. Gene-level association analysis of systemic sclerosis: A comparison of African-Americans and White populations. PLoS One. 2018; 13(1):e0189498.
    View in: PubMed
    Score: 0.012
  4. Association of Smoking with Metabolic Volatile Organic Compounds in Exhaled Breath. Int J Mol Sci. 2017 Oct 25; 18(11).
    View in: PubMed
    Score: 0.012
  5. Downstream targets of GWAS-detected genes for breast, lung, and prostate and colon cancer converge to G1/S transition pathway. Hum Mol Genet. 2017 04 15; 26(8):1465-1471.
    View in: PubMed
    Score: 0.011
  6. Modeling the natural history and detection of lung cancer based on smoking behavior. PLoS One. 2014; 9(4):e93430.
    View in: PubMed
    Score: 0.009
  7. Genes with a large intronic burden show greater evolutionary conservation on the protein level. BMC Evol Biol. 2014 Mar 16; 14(1):50.
    View in: PubMed
    Score: 0.009
  8. Associations between dietary intake of choline and betaine and lung cancer risk. PLoS One. 2013; 8(2):e54561.
    View in: PubMed
    Score: 0.008
  9. Derived SNP alleles are used more frequently than ancestral alleles as risk-associated variants in common human diseases. J Bioinform Comput Biol. 2012 Apr; 10(2):1241008.
    View in: PubMed
    Score: 0.008
  10. Beyond comparing means: the usefulness of analyzing interindividual variation in gene expression for identifying genes associated with cancer development. J Bioinform Comput Biol. 2012 Apr; 10(2):1241013.
    View in: PubMed
    Score: 0.008
  11. Initial medical attention on patients with early-stage non-small cell lung cancer. PLoS One. 2012; 7(3):e32644.
    View in: PubMed
    Score: 0.008
  12. Dietary patterns affect lung cancer risk in never smokers. Nutr Cancer. 2011; 63(6):842-9.
    View in: PubMed
    Score: 0.008
  13. Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy. PLoS Genet. 2011 Jul; 7(7):e1002178.
    View in: PubMed
    Score: 0.008
  14. Association of smoking with tumor size at diagnosis in non-small cell lung cancer. Lung Cancer. 2011 Dec; 74(3):378-83.
    View in: PubMed
    Score: 0.008
  15. Adjusting a cancer mortality-prediction model for disease status-related eligibility criteria. BMC Med Res Methodol. 2011 May 11; 11:64.
    View in: PubMed
    Score: 0.007
  16. A smoking-based carcinogenesis model for lung cancer risk prediction. Int J Cancer. 2011 Oct 15; 129(8):1907-13.
    View in: PubMed
    Score: 0.007
  17. Estimation of the effects of smoking and DNA repair capacity on coefficients of a carcinogenesis model for lung cancer. Int J Cancer. 2009 May 01; 124(9):2152-8.
    View in: PubMed
    Score: 0.007
  18. DNA repair capacity and lung cancer risk in never smokers. Cancer Epidemiol Biomarkers Prev. 2008 Jun; 17(6):1322-8.
    View in: PubMed
    Score: 0.006
  19. Aggregation of cancer among relatives of never-smoking lung cancer patients. Int J Cancer. 2007 Jul 01; 121(1):111-8.
    View in: PubMed
    Score: 0.006
  20. Imprinting detection by extending a regression-based QTL analysis method. Hum Genet. 2007 Sep; 122(2):159-74.
    View in: PubMed
    Score: 0.006
  21. Never smokers and lung cancer risk: a case-control study of epidemiological factors. Int J Cancer. 2006 Apr 01; 118(7):1798-804.
    View in: PubMed
    Score: 0.005
  22. Estimating the growth rates of primary lung tumours from samples with missing measurements. Stat Med. 2005 Apr 15; 24(7):1117-34.
    View in: PubMed
    Score: 0.005
  23. Strength of selection in lung tumors correlates with clinical features better than tumor mutation burden. Sci Rep. 2024 06 03; 14(1):12732.
    View in: PubMed
    Score: 0.005
  24. Identification of genetically predicted DNA methylation markers associated with non-small cell lung cancer risk among 34,964 cases and 448,579 controls. Cancer. 2024 03 15; 130(6):913-926.
    View in: PubMed
    Score: 0.004
  25. Genetic linkage and imprinting effects on body mass index in children and young adults. Eur J Hum Genet. 2003 Jun; 11(6):425-32.
    View in: PubMed
    Score: 0.004
  26. Genome-wide association study of lung adenocarcinoma in East Asia and comparison with a European population. Nat Commun. 2023 05 26; 14(1):3043.
    View in: PubMed
    Score: 0.004
  27. Mosaic Chromosomal Alterations Are Associated With Increased Lung Cancer Risk: Insight From the INTEGRAL-ILCCO Cohort Analysis. J Thorac Oncol. 2023 08; 18(8):1003-1016.
    View in: PubMed
    Score: 0.004
  28. Immune Infiltration in Tumor and Adjacent Non-Neoplastic Regions Codetermines Patient Clinical Outcomes in Early-Stage Lung Cancer. J Thorac Oncol. 2023 09; 18(9):1184-1198.
    View in: PubMed
    Score: 0.004
  29. Methylation of nonessential genes in cutaneous melanoma - Rule Out hypothesis. Melanoma Res. 2023 06 01; 33(3):163-172.
    View in: PubMed
    Score: 0.004
  30. Genetic susceptibility for lung cancer: interactions with gender and smoking history and impact on early detection policies. Hum Hered. 2003; 56(1-3):139-45.
    View in: PubMed
    Score: 0.004
  31. Power of a simplified multivariate test for genetic linkage. Ann Hum Genet. 2002 Nov; 66(Pt 5-6):407-17.
    View in: PubMed
    Score: 0.004
  32. Cross-ancestry genome-wide meta-analysis of 61,047 cases and 947,237 controls identifies new susceptibility loci contributing to lung cancer. Nat Genet. 2022 08; 54(8):1167-1177.
    View in: PubMed
    Score: 0.004
  33. Tumor somatic mutations also existing as germline polymorphisms may help to identify functional SNPs from genome-wide association studies. Carcinogenesis. 2020 10 15; 41(10):1353-1362.
    View in: PubMed
    Score: 0.004
  34. Genetics of Smoking Behaviors in American Indians. Cancer Epidemiol Biomarkers Prev. 2020 11; 29(11):2180-2186.
    View in: PubMed
    Score: 0.004
  35. Human genes differ by their UV sensitivity estimated through analysis of UV-induced silent mutations in melanoma. Hum Mutat. 2020 10; 41(10):1751-1760.
    View in: PubMed
    Score: 0.004
  36. Protein-altering germline mutations implicate novel genes related to lung cancer development. Nat Commun. 2020 05 11; 11(1):2220.
    View in: PubMed
    Score: 0.003
  37. Association Analysis of Driver Gene-Related Genetic Variants Identified Novel Lung Cancer Susceptibility Loci with 20,871 Lung Cancer Cases and 15,971 Controls. Cancer Epidemiol Biomarkers Prev. 2020 07; 29(7):1423-1429.
    View in: PubMed
    Score: 0.003
  38. SNP eQTL status and eQTL density in the adjacent region of the SNP are associated with its statistical significance in GWA studies. BMC Genet. 2019 11 12; 20(1):85.
    View in: PubMed
    Score: 0.003
  39. Lung Cancer Risk in Never-Smokers of European Descent is Associated With Genetic Variation in the 5p15.33 TERT-CLPTM1Ll Region. J Thorac Oncol. 2019 08; 14(8):1360-1369.
    View in: PubMed
    Score: 0.003
  40. Untouchable genes in the human genome: Identifying ideal targets for cancer treatment. Cancer Genet. 2019 02; 231-232:67-79.
    View in: PubMed
    Score: 0.003
  41. Gene characteristics predicting missense, nonsense and frameshift mutations in tumor samples. BMC Bioinformatics. 2018 Nov 19; 19(1):430.
    View in: PubMed
    Score: 0.003
  42. Identification of susceptibility pathways for the role of chromosome 15q25.1 in modifying lung cancer risk. Nat Commun. 2018 08 13; 9(1):3221.
    View in: PubMed
    Score: 0.003
  43. Genome-wide interaction study of smoking behavior and non-small cell lung cancer risk in Caucasian population. Carcinogenesis. 2018 03 08; 39(3):336-346.
    View in: PubMed
    Score: 0.003
  44. Genetic susceptibility loci of idiopathic interstitial pneumonia do not represent risk for systemic sclerosis: a case control study in Caucasian patients. Arthritis Res Ther. 2016 Jan 20; 18:20.
    View in: PubMed
    Score: 0.003
  45. Prediction of the gene expression in normal lung tissue by the gene expression in blood. BMC Med Genomics. 2015 Nov 17; 8:77.
    View in: PubMed
    Score: 0.003
  46. Allelic Spectra of Risk SNPs Are Different for Environment/Lifestyle Dependent versus Independent Diseases. PLoS Genet. 2015 Jul; 11(7):e1005371.
    View in: PubMed
    Score: 0.003
  47. Identification of IL12RB1 as a novel systemic sclerosis susceptibility locus. Arthritis Rheumatol. 2014 Dec; 66(12):3521-3.
    View in: PubMed
    Score: 0.002
  48. SNP characteristics predict replication success in association studies. Hum Genet. 2014 Dec; 133(12):1477-86.
    View in: PubMed
    Score: 0.002
  49. The IRF5-TNPO3 association with systemic lupus erythematosus has two components that other autoimmune disorders variably share. Hum Mol Genet. 2015 Jan 15; 24(2):582-96.
    View in: PubMed
    Score: 0.002
  50. How to get the most from microarray data: advice from reverse genomics. BMC Genomics. 2014 Mar 21; 15:223.
    View in: PubMed
    Score: 0.002
  51. Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis. Am J Hum Genet. 2014 Jan 02; 94(1):47-61.
    View in: PubMed
    Score: 0.002
  52. A systemic sclerosis and systemic lupus erythematosus pan-meta-GWAS reveals new shared susceptibility loci. Hum Mol Genet. 2013 Oct 01; 22(19):4021-9.
    View in: PubMed
    Score: 0.002
  53. Building a statistical model for predicting cancer genes. PLoS One. 2012; 7(11):e49175.
    View in: PubMed
    Score: 0.002
  54. Genome-wide association study reveals novel genetic determinants of DNA repair capacity in lung cancer. Cancer Res. 2013 Jan 01; 73(1):256-64.
    View in: PubMed
    Score: 0.002
  55. Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study. Ann Rheum Dis. 2013 Apr; 72(4):602-7.
    View in: PubMed
    Score: 0.002
  56. Chapter 11: Rice-MD Anderson lung cancer model. Risk Anal. 2012 Jul; 32 Suppl 1:S142-50.
    View in: PubMed
    Score: 0.002
  57. IRF5 polymorphism predicts prognosis in patients with systemic sclerosis. Ann Rheum Dis. 2012 Jul; 71(7):1197-202.
    View in: PubMed
    Score: 0.002
  58. Impact of reduced tobacco smoking on lung cancer mortality in the United States during 1975-2000. J Natl Cancer Inst. 2012 Apr 04; 104(7):541-8.
    View in: PubMed
    Score: 0.002
  59. A GWAS follow-up study reveals the association of the IL12RB2 gene with systemic sclerosis in Caucasian populations. Hum Mol Genet. 2012 Feb 15; 21(4):926-33.
    View in: PubMed
    Score: 0.002
  60. Cigarette smoking is not a risk factor for systemic sclerosis. Arthritis Rheum. 2011 Oct; 63(10):3098-102.
    View in: PubMed
    Score: 0.002
  61. Variants in inflammation genes are implicated in risk of lung cancer in never smokers exposed to second-hand smoke. Cancer Discov. 2011 Oct; 1(5):420-9.
    View in: PubMed
    Score: 0.002
  62. Modeling the mortality reduction due to computed tomography screening for lung cancer. Cancer. 2011 Jun 15; 117(12):2703-8.
    View in: PubMed
    Score: 0.002
  63. Assessment of lung-cancer mortality reduction from CT Screening. Lung Cancer. 2011 Mar; 71(3):328-32.
    View in: PubMed
    Score: 0.002
  64. Prioritizing genes associated with prostate cancer development. BMC Cancer. 2010 Nov 02; 10:599.
    View in: PubMed
    Score: 0.002
  65. Evolutionary evidence of the effect of rare variants on disease etiology. Clin Genet. 2011 Mar; 79(3):199-206.
    View in: PubMed
    Score: 0.002
  66. Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus. Nat Genet. 2010 May; 42(5):426-9.
    View in: PubMed
    Score: 0.002
  67. GWAS meets microarray: are the results of genome-wide association studies and gene-expression profiling consistent? Prostate cancer as an example. PLoS One. 2009 Aug 04; 4(8):e6511.
    View in: PubMed
    Score: 0.002
  68. Relative effects of mutability and selection on single nucleotide polymorphisms in transcribed regions of the human genome. BMC Genomics. 2008 Jun 17; 9:292.
    View in: PubMed
    Score: 0.002
  69. Shifting paradigm of association studies: value of rare single-nucleotide polymorphisms. Am J Hum Genet. 2008 Jan; 82(1):100-12.
    View in: PubMed
    Score: 0.001
  70. Interplay between mutagen sensitivity and epidemiological factors in modulatinglung cancer risk. Int J Cancer. 2007 Jun 15; 120(12):2687-95.
    View in: PubMed
    Score: 0.001
  71. Re: "Cancer mortality among US men and women with asthma and hay fever". Am J Epidemiol. 2006 Feb 15; 163(4):394-5; author reply 395-6.
    View in: PubMed
    Score: 0.001
  72. Predicting the oncogenicity of missense mutations reported in the International Agency for Cancer Research (IARC) mutation database on p53. Hum Mutat. 2005 Nov; 26(5):446-54.
    View in: PubMed
    Score: 0.001
  73. Possible genomic imprinting of three human obesity-related genetic loci. Am J Hum Genet. 2005 Mar; 76(3):427-37.
    View in: PubMed
    Score: 0.001
  74. Missense mutations in hMLH1 and hMSH2 are associated with exonic splicing enhancers. Am J Hum Genet. 2003 Nov; 73(5):1157-61.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.